StonvexLoading…
StonvexCore line items from TSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-28 | Q4 2025 2025-12-27 | Annual 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $27.97B | $14.31B | $54.44B | $40.58B |
Operating Income | $737.00M | $302.00M | $1.10B | $940.00M |
Net Income | $345.00M | $85.00M | $474.00M | $427.00M |
EPS (Diluted) | $0.97 | $0.24 | $1.33 | $1.20 |
Total Assets | $35.16B | $36.02B | $36.66B | $36.46B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $500.00M | $1.28B | $1.23B | $1.55B |
Free Cash Flow OCF − CapEx | $432.00M | $690.00M | $1.18B | $929.00M |
Shares Outstanding | 354.00M | 354.00M | 357.00M | 357.00M |